| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c429c1b80057c845e7ebb8d4bae5060b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7dd54f1a4a12868ae7731ed0f2a8ecbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be5873257210d84abde4a08b2c1f2e1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86d8a0a63bd767b4058505db905c22cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c627260b1ba098b252d2690757a9df7c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2016-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_125865b27194de89344c2c92b39951f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d9088a9f8a3776a84cdfffab3c95927
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9d1160c50ad204cdbf018e69e66fa49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c628d0c4e4a8e7709952deaea137ad95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1cf2a5574f9fedfa4a36e177d0aea70 |
| publicationDate |
2018-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018177872-A1 |
| titleOfInvention |
Combination of PD-1 antagonist with an EGFR inhibitor |
| abstract |
The present invention relates to a pharmaceutical composition comprising PD-1 antagonist and an EGFR Inhibitor. The present combination can be administered independently or separately, in a quantity which is jointly therapeutically effective for the treatment of cancer. The invention also provides the use of such a combination for the manufacture of a medicament; the use of such a combination as a medicine; a kit of part comprising such a combination; and a method of treatment of such a combination. |
| priorityDate |
2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |